Predicting HIV RNA virologic outcome at 52-weeks follow-up in antiretroviral clinical trials

Journal of Acquired Immune Deficiency Syndromes

Volumn 24, Issue 5, 2000, Pages 433-439

  Raboud, J M ^a   Rae, S ^a   Montaner, J S G ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Providence Health Care   (Canada)

Author keywords

Plasma viral load; Prediction; ROC curve; Virologic outcome

Indexed keywords

ANTIVIRUS AGENT; DIDANOSINE; NEVIRAPINE; VIRUS RNA; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MULTICENTER STUDY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0034662742     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200008150-00006     Document Type: Article

References (9)

1. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals
2. 1998 Revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals
3. A randomized, double-blinded trial comparing combinations of nevirapine, didanosine and zidovudine for HIV infected patients. The INCAS trial
4. AVANTI-2: Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients
5. AVANTI-3: A randomized double-blind, comparative trial to evaluate the efficacy, safety and tolerance of AZT/3TC vs AZT/3TC/nelfinavir in antiretroviral naive patients
6. Rapid and simple PCR assay for quantitation of human immunodeficiency virus Type 1 RNA in plasma: Application to acute retroviral infection
7. A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: Enhanced sensitivity
8. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma
9. The meaning and use of the area under a receiver operating characteristic curve